Humacyte Inc (HUMA)

NASDAQ
3.19
+0.06(+1.92%)
After Hours
3.20
+0.01(+0.31%)
- Real-time Data
  • Volume:
    132,100
  • Day's Range:
    3.05 - 3.20
  • 52 wk Range:
    1.96 - 8.04

HUMA Overview

Prev. Close
3.13
Day's Range
3.05-3.2
Revenue
1.56M
Open
3.08
52 wk Range
1.96-8.04
EPS
0.333
Volume
132,100
Market Cap
328.95M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
345,253
P/E Ratio
9.37
Beta
0.92
1-Year Change
-40.04%
Shares Outstanding
103,118,461
Next Earnings Date
Mar 28, 2023
What is your sentiment on Humacyte?
or
Market is currently closed. Voting is open during market hours.

Humacyte Inc News

Humacyte Inc Company Profile

Humacyte Inc Company Profile

Humacyte, Inc. is engaged in the development and manufacturing of off-the-shelf, universally implantable, bioengineered human tissues. It is developing a portfolio of human acellular vessels (HAVs) with varying diameters and lengths. The HAV cabinet would initially target the vascular repair, reconstruction and replacement market, including vascular trauma; atrioventricular (AV) access for hemodialysis; peripheral arterial disease (PAD); and coronary artery bypass grafting (CABG). The Company has developed a paradigm for manufacturing human tissues that is intended to mimic key aspects of human physiology. It is developing and manufacturing acellular tissues to address life- and limb-threatening vascular conditions while focusing on potential future applications for complex tissue and organ diseases. It is also engaged in developing its HAVs for pediatric heart surgery and the delivery of cellular therapies, including pancreatic islet cell transplantation to treat Type 1 diabetes.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • While waiting for the catalyst, 4.60 was added. Flying to the moon is a matter of time 🚀🤑
    0
    • Guys, buy STPC be4 too late
      0